Ipca Labs Board Meeting on May 29, 2026 to Consider Results, Dividend

Ipca Laboratories Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the standalone and consolidated audited financial results for the fourth quarter and financial year ended March 31, 2026. The board will also consider the recommendation of a dividend for the financial year 2025-26. The trading window for insiders remains closed from April 1, 2026, until 48 hours after the declaration of the results, i.e., until May 31, 2026.